Estimating covariate-adjusted log hazard ratios in randomized clinical trials using cox proportional hazards models and nonparametric randomization based analysis of covariance

Journal of Biopharmaceutical Statistics

Volumn 23, Issue 2, 2013, Pages 477-490

  Saville, Benjamin R ^a   Koch, Gary G ^b  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b IL   (United States)

Author keywords

Analysis of covariance; Cox proportional hazards; Hazard ratio; Linear models equating covariate means; Lung disease; Multivariate survival; Weighted least squares

Indexed keywords

ANALYSIS OF COVARIANCE; ARTICLE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HAZARD RATIO; HUMAN; LUNG FUNCTION; NONPARAMETRIC TEST; NORMAL DISTRIBUTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RANDOM SAMPLE; RANDOMIZATION; STRATIFIED SAMPLE; SURVIVAL;

ADULT; AGED; ANALYSIS OF VARIANCE; FEMALE; HUMANS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RANDOM ALLOCATION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; STATISTICS, NONPARAMETRIC;

EID: 84874451769     PISSN: 10543406     EISSN: 15205711     Source Type: Journal    
DOI: 10.1080/10543406.2012.755692     Document Type: Article

References (23)

1. Calverley, P. M. A., Anderson, J. A., Celli, B., Ferguson, G. T., Jenkins, C., Jones, P. W., Yates, J. C., Vestbo, J. (2007). Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. New England Journal of Medicine 356:775-789.
2. Cox, D. R. (1972). Regression models and life-tables. Journal of the Royal Statistical Society, Series B 34:187-220.
3. Davis, C. E., Quade, D. (1968). On comparing the correlations within two pairs of variables. Biometrics 24:987-995.
4. Davis, C. E., Quade, D. (1978). U-statistics for skewness and symmetry. Communications in Statistics A 7:413-418.
5. Ford, I., Norrie, J. (2002). The role of covariates in estimating treatment effects and risk in long-term clinical trials. Statistics in Medicine 21:2899-2908.
6. Gail, M. H., Wieand, S., Piantadosi, S. (1984). Biased estimates of treatment effect in randomized experiments with nonlinear regressions and omitted covariates. Biometrika 71:431-444.
7. Gehan, E. (1965). A generalized Wilcoxon test for comparing arbitrary single-censored samples. Biometrika 52:203-223.
8. Jiang, H., Symanowski, J., Paul, S., Qu, Y., Zagar, A., Hong, S. (2008). The type I error and power of non-parametric logrank and Wilcoxon tests with adjustment for covariates - A simulation study. Statistics in Medicine 27:5850-5860.
9. Kawaguchi, A., Koch, G. G., Wang, X. (2011). Stratified multivariate MannYWhitney estimators for the comparison of two treatments with randomization based covariance adjustment. Statistics in Biopharmaceutical Research 3:217-231.
10. Koch, G. G., Tangen, C. M., Jung, J.-W., Amara, I. A. (1998). Issues for covariance analysis of dichotomous and ordered categorical data from randomized clinical trials and nonparametric strategies for addressing them. Statistics in Medicine 17:1863-1892.
11. LaVange, L. M., Durham, T. A., Koch, G. G. (2005). Randomization-based nonparametric methods for the analysis of multicentre trials. Statistical Methods in Medical Research 14:281-301.
12. Lewis, J. A., Jones, D. R., Rohmel, J. (1995). Biostatistical methodology in clinical trials - A European guideline. Statistics in Medicine 14:1655-1682.
13. Moodie, P. F., Saville, B. R., Koch, G. G., Tangen, C. M. (2011). Estimating covariate-adjusted log hazard ratios for multiple time intervals in clinical trials using nonparametric randomization based ANCOVA. Statistics in Biopharmaceutical Research 3:232-241.
14. Pauwels, R., Buist, A. S., Calverley, P. M. A., Jenkins, C. R., Hurd, S. S., on behalf of the GOLD Scientific Committee (2001). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO global initiative for chronic obstructive lung disease (gold) workshop summary. Amercian Journal of Respiration Critical Care Medicine 163:1256-1276.
15. Peto, R., Peto, J. (1972). Asymptotically efficient rank invariant test procedures (with discussion). Journal of the Royal Statistical Society, Series B 34:205-207.
16. Quanjer, P. H. (1993). Standardization of lung function testings. Official statement of the European Respiratory Society. European Respiratory Journal 6:5-40.
17. Robinson, L. D., Jewell, N. P. (1991). Some surprising results about covariate adjustment in logistic regression models. International Statistical Review 58:227-240.
18. Saville, B. R., Herring, A. H., Koch, G. G. (2010). A robust method for comparing two treatments in a confirmatory clinical trial via multivariate time-to-event methods that jointly incorporate information from longitudinal and time-to-event data. Statistics in Medicine 29:75-85.
19. Stokes, M. E., Davis, C. S., Koch, G. G. (2000). Categorical Data Analysis Using the SAS System, 2nd ed. Cary, NC: SAS Institute Inc.
20. Tangen, C. M., Koch, G. G. (1999a). Complementary nonparametric analysis of covariance of logistic regression in a randomized clinical trial setting. Journal of Biopharmaceutical Statistics 9:45-66.
21. Tangen, C. M., Koch, G. G. (1999b). Nonparametric analysis of covariance for hypothesis testing with logrank and Wilcoxon scores and survival-rate estimation in a randomized clinical trial. Journal of Biopharmaceutical Statistics 9:307-338.
22. Tangen, C. M., Koch, G. G. (2000). Non-parametric covariance methods for incidence density analyses of time-to-event data from a randomized clinical trial and their complementary roles to proportional hazards regression. Statistics in Medicine 19:1039-1058.
23. Wei, L. J., Lin, D. Y., Weissfeld, L. (1989). Regression analysis of multivariate incomplete failure time data by modeling marginal distributions. Journal of the American Statistical Association 84:1065-1073.